Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:04 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1585–1608 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Complex Atypical Hyperplasia, Endometrial Cancer
Interventions: Metformin; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Cincinnati, Ohio

Conditions: Pain
Interventions: 2% lidocaine gel, placebo; Drug · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Health Behavior
Interventions: Fitbit Care intervention arm; Combination Product
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 597 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Pulmonary Hypertension, Congestive Heart Failure(CHF), Valve Disease, Heart
Interventions: Not listed
Lead sponsor: HemoCept Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Symptomatic Femoro-popliteal Chronic Total Occlusion
Interventions: TruePath CTO Device, CROSSER CTO Device; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Dysphonia, Aphonia
Interventions: Surface Electromyography; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 110 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes, Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 2, Prediabetes
Interventions: KOS Argus Continuous Glucose Monitoring System; Device
Lead sponsor: KOS Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Mateo, California

Conditions: Mobility Limitation
Interventions: Lofstrand Crutches, Axillary Crutches; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 45 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Healthy
Interventions: Guselkumab; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 440 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Atrial Fibrillation
Interventions: CRM Device; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 5,379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Sylmar, California

Conditions: Comfort, Tolerability
Interventions: Study Procedures; Other
Lead sponsor: National Center for Occupational Health and Infection Control; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 382 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Asthma
Interventions: fenoTRACK Device; Device
Lead sponsor: Biometry Inc; Industry
Eligibility: 5 Years to 100 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 13
States / cities: Stockton, California • Panama City, Florida • Columbus, Georgia + 10 more

Conditions: Physical Activity, Blood Pressure
Interventions: Stair Walking; Behavioral
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 35 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Cardiomyopathy, Cardiovascular Disease, Heart Disease
Interventions: Respiratory Depression Monitoring with End Tidal Carbon Dioxide Nasal Cannula (ETCO2- NC), Standard Non-invasive Respiratory Depression Monitoring; Device · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Stroke, Transient Ischemic Attack
Interventions: Antithrombotic treatment, percutaneous device closure of PFO; Drug · Device
Lead sponsor: Insel Gruppe AG, University Hospital Bern; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2021
U.S. locations: 3
States / cities: Boston, Massachusetts • Springfield, Massachusetts • Tyler, Texas

Conditions: Sepsis
Interventions: Blood sampling; Device
Lead sponsor: Abionic SA; Industry
Eligibility: 18 Years and older
Enrollment: 544 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 5
States / cities: Chicago, Illinois • Lexington, Kentucky • Toledo, Ohio + 1 more

Conditions: Cough
Interventions: Dextromethorphan Hydrobromide, Placebo, Cough recording device; Drug · Device
Lead sponsor: Pfizer; Industry
Eligibility: 6 Years to 11 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 18
States / cities: DeLand, Florida • Orlando, Florida • Blackfoot, Idaho + 13 more

Conditions: Achondroplasia
Interventions: BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe; Combination Product · Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Dental Plaque
Interventions: Automated mouthpiece-based toothbrush, Manual toothbrush; Device
Lead sponsor: University of Washington; Other
Eligibility: 5 Years to 17 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Stoma Ileostomy
Interventions: Not listed
Lead sponsor: Coloplast A/S; Industry
Eligibility: 6 Months to 4 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Corpus Christi, Texas

Conditions: Childbirth
Interventions: Materna Prep Device, Sham Control; Device
Lead sponsor: Materna Medical; Industry
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Mountain View, California

Conditions: Ulcerative Colitis
Interventions: UCRI; Diagnostic Test
Lead sponsor: Glycominds, LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Migraine With Aura
Interventions: Partial Rebreathing Device, Sham breathing device; Device
Lead sponsor: Rehaler; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 9
States / cities: Palo Alto, California • Pasadena, California • Riverside, California + 6 more

Conditions: Obstructive Sleep Apnea
Interventions: BONGO DEVICE; Device
Lead sponsor: InnoMed Healthscience Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Alameda, California

Search by objective public record fields.

Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

Intracervical Lidocaine Gel for IUD Insertional Pain

Impact of Wearable Health Devices and Wellness Behavior Change Support on Health Outcomes and Healthcare Costs

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

The Lumen Study: Comparing Devices for Patients With Symptomatic Femoro-popliteal Chronic Total Occlusion (CTO)

A Personalized Voice Restoration Device for Patients With Laryngectomy

Argus 2.0 Adoption Study

Mobility Impairment in the Northern Region of Malawi

A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants

RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population

Assessment of Novel Respiratory Protective Devices in Healthcare

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

Can RFID Technology Capture Stair Walking

Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients

International PFO Consortium

Evaluation of Immunoassay Measurements of Pancreatic Stone Protein Performed on abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis

Dextromethorphan Pediatric Acute Cough Study

Bioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy Participants

Efficacy of Plaque Removal of a Novel Brushing Device

Post Market Clinical Follow-up Study Evaluating Performance and Safety of the SenSura® Mio Kids Device

A Clinical Phase II Study of the Materna Device to Shorten Delivery Time During Childbirth

Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.

PArtial REbreathing for Migraine With Aura 1

Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)